Abstract The Alzheimer's Disease Neuroimaging Initiative (ADNI) is an ongoing,
longitudinal, multicenter study designed to develop clinical, imaging, genetic, and …

Background Electroconvulsive therapy (ECT) elicits a rapid and robust clinical response in
patients with refractory depression. Neuroimaging measurements of structural plasticity …

Surface based 3D shape analysis plays a fundamental role in computer vision and medical
imaging. This work proposes to use optimal mass transport map for shape matching and …

A wealth of empirical evidence is accumulating on the genetic mediation of brain structure
phenotypes. This comes from twin studies that assess heritability and genetic covariance …

Despite many neuroimaging studies in the past years, the neuroanatomical substrates of
major depressive disorder (MDD) subcortical structures are still not well understood. Since …

The use of imaging markers to predict clinical outcomes can have a great impact in public
health. The aim of this article is to develop a class of generalized scalar-on-image …

Increasing evidence has shown a higher sensitivity of Alzheimer's disease (AD) progression
by local hippocampal atrophy rather than the whole volume. However, existing …

The apolipoprotein E (APOE) e4 genotype is a powerful risk factor for late-onset Alzheimer's
disease (AD). In the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort, we …

We consider a functional linear Cox regression model for characterizing the association
between time‐to‐event data and a set of functional and scalar predictors. The functional …

The apolipoprotein E (APOE) e4 allele is the most prevalent genetic risk factor for
Alzheimer's disease (AD). Hippocampal volumes are generally smaller in AD patients …